Correlation Between Bank of America and CureVac NV

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bank of America and CureVac NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and CureVac NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank of America and CureVac NV, you can compare the effects of market volatilities on Bank of America and CureVac NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of CureVac NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and CureVac NV.

Diversification Opportunities for Bank of America and CureVac NV

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between Bank and CureVac is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and CureVac NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CureVac NV and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with CureVac NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CureVac NV has no effect on the direction of Bank of America i.e., Bank of America and CureVac NV go up and down completely randomly.

Pair Corralation between Bank of America and CureVac NV

Considering the 90-day investment horizon Bank of America is expected to generate 0.33 times more return on investment than CureVac NV. However, Bank of America is 2.99 times less risky than CureVac NV. It trades about -0.02 of its potential returns per unit of risk. CureVac NV is currently generating about -0.02 per unit of risk. If you would invest  4,363  in Bank of America on December 28, 2024 and sell it today you would lose (107.00) from holding Bank of America or give up 2.45% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Bank of America  vs.  CureVac NV

 Performance 
       Timeline  
Bank of America 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Bank of America has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Bank of America is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
CureVac NV 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days CureVac NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, CureVac NV is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Bank of America and CureVac NV Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bank of America and CureVac NV

The main advantage of trading using opposite Bank of America and CureVac NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, CureVac NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CureVac NV will offset losses from the drop in CureVac NV's long position.
The idea behind Bank of America and CureVac NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing